Organization | Therapeutic Concepts

Therapeutic Concepts Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial

2005

NCT00116636

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2015

Timeline

NOW

Now

Alternative names

Therapeutic Concepts, PA | Therapeutic Concepts, P.A.

Active Ingredients

Drugs in Phase 4 Trials (8)

abacavir (ziagen) (1 trial)

cobicistat (stribild) (1 trial)

darunavir (prezista) (1 trial)

etravirine (intelence) (1 trial)

lamivudine (epivir) (1 trial)

lopinavir (Kaletra) (2 trials)

rilpivirine (edurant) (1 trial)

ritonavir (Norvir) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

HIV Infections (Phase 4)

HIV Seropositivity (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 4
# of Trial APIs: 8